Search

everythinglearnresearchcommunity

for

Search:↓

People with male pattern baldness are more likely to have metabolic syndrome.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Wearing a cap doesn't affect quality of life for Indian men with hair loss, but severe hair loss does lower it. Older men have more severe hair loss, and those who wear caps more often want less treatment.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Review finds no permanent solution for female hair loss.

Review determines effective, safe treatments for female hair loss.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Hair loss in young men in Central India is linked to severe heart disease.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Using your own platelet-rich plasma (PRP) can effectively treat hair loss, increasing hair density and width with no side effects.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

There's no significant link between hair loss from male pattern baldness and early heart disease.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Finasteride helps reduce heart enlargement in heart failure patients.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Men with early hair loss may have higher health risks similar to women with PCOS.

Niosomal minoxidil, when applied topically, increases hair count more than conventional minoxidil solution.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

PCOS is a long-term condition that needs more research for better understanding and treatment.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

PRP therapy helps improve hair growth and is safe for treating hair loss.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.